Edition:
United Kingdom

CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

14.98HKD
24 Apr 2019
Change (% chg)

-- (--)
Prev Close
HK$14.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
40,255,974
52-wk High
HK$26.75
52-wk Low
HK$9.90

Latest Key Developments (Source: Significant Developments)

CSPC Pharmaceutical Group Says "SYHA1803" Granted Clinical Trial Approval By NMPA China
Friday, 12 Apr 2019 

April 12 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::"SYHA1803" GRANTED APPROVAL BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA TO CONDUCT CLINICAL TRIALS IN CHINA.  Full Article

CSPC Pharmaceutical Group Says "SYHA1402" ‍Granted Clinical Trial Approval By NMPA China ​
Friday, 12 Apr 2019 

April 12 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::"SYHA1402" GRANTED APPROVAL BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA TO CONDUCT CLINICAL TRIALS IN CHINA.  Full Article

CSPC Pharmaceutical Group Unit To Acquire All Shares In Yong Shun
Monday, 7 Jan 2019 

Jan 7 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::DRAGON MERIT WILL ACQUIRE ALL ISSUED SHARES IN YONG SHUN FOR RMB252.9 MILLION.  Full Article

CSPC Pharmaceutical Group Says Unit To Buy 29.9 Pct Stake In CSPC Yuanda For RMB28 Mln
Monday, 6 Aug 2018 

Aug 6 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::UNIT TO BUY 29.9% EQUITY INTEREST IN CSPC YUANDA FROM CSPC HOLDINGS AT A CONSIDERATION OF RMB28 MILLION.  Full Article

CSPC Pharmaceutical Group Appoints Wang Zhenguo as Vice-Chairman And Rotating CEO
Friday, 25 May 2018 

May 25 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::PAN WEIDONG CEASED AS ROTATING CHIEF EXECUTIVE OFFICER.WANG ZHENGUO HAS BEEN APPOINTED AS VICE-CHAIRMAN AND ROTATING CHIEF EXECUTIVE OFFICER.PAN WEIDONG REMAINS AS EXECUTIVE DIRECTOR AND VICE- CHAIRMAN OF CO.  Full Article

CSPC Pharmaceutical Group Says FY Profit Attributable HK$2.77 Bln
Monday, 19 Mar 2018 

March 19 (Reuters) - Cspc Pharmaceutical Group Ltd <1093.HK>::FY REVENUE HK$ ‍15.46​ BILLION VERSUS HK$12.37 BILLION.FY PROFIT ATTRIBUTABLE HK$2.77 BILLION VERSUS HK$2.10 BILLION.‍FINAL DIVIDEND PER SHARE HK15.00 CENTS​.  Full Article

CSPC Pharmaceutical Group Says ‍Cancer Drug Granted Drug Clinical Trial Approval By China FDA
Friday, 16 Mar 2018 

March 16 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::‍CANCER DRUG DEVELOPED BY WUHAN YZY BIOPHARMA​ GRANTED DRUG CLINICAL TRIAL APPROVAL BY CHINA FDA.  Full Article

CSPC Pharmaceutical Group Announces Acquisition Of Stake In Wuhan Yzy Biopharma Co
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - CSPC Pharmaceutical Group <1093.HK>::ACQUISITION OF 39.56% EQUITY INTEREST IN WUHAN YZY BIOPHARMA CO., LTD.DEAL FOR UP TO RMB356 MILLION.  Full Article

CSPC Pharmaceutical Group Says Unit's Listing Application To CSRC Was Accepted
Wednesday, 27 Dec 2017 

Dec 27 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CSPC XNW SUBMITTED APPLICATION TO CSRC FOR PROPOSED A SHARE LISTING ON CHINEXT OF SZSE & RECEIVED NOTICE OF ACCEPTANCE.‍EXPECTED THAT CSPC XNW WILL REMAIN AS AN INDIRECT SUBSIDIARY OF CO.  Full Article

CSPC Pharmaceutical Group announces change of shareholdings of substantial shareholder
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Cspc Pharmaceutical Group Ltd <1093.HK>:‍Massive Giant Group transferred approximately 6.78% of total issued shares to Common Success International​.  Full Article

Hong Kong stocks end flat after China's GDP data

* HK->Shanghai Connect daily quota used 0 pct, Shanghai->HK daily quota used 0.7 pct